Helping Eye Cells Take Out Their Trash May Protect the Optic Nerve From Glaucoma

This audio article is from VisualFieldTest.com.Read the full article here: https://visualfieldtest.com/en/helping-eye-cells-take-out-their-trash-may-protect-the-optic-nerve-from-glaucomaTest your visual field online: https://visualfieldtest.comSupport the show so new episodes keep coming: https://www.buzzsprout.com/2563091/supportExcerpt:Helping Eye Cells Take Out Their Trash May Protect the Optic Nerve From Glaucoma Evidence review current to September 2, 2026 Introduction Lowering eye pressure remains the most proven way to slow glaucoma. Yet some people continue to lose retinal nerve tissue and vision even when their eye pressure is considered controlled. This is especially relevant in normal-tension glaucoma, but it can also occur in ordinary open-angle glaucoma after pressure-lowering treatment. One possible explanation is that pressure is only the initial stress. The lasting damage may also depend on whether retinal ganglion cells can maintain their mitochondria, transport cellular cargo along their axons, control oxidative stress, and remove damaged cell parts. A study published in 2026 provides some of the clearest evidence so far for this idea. The investigators used Torin 2, a powerful laboratory inhibitor of the mechanistic target of rapamycin pathway, to increase autophagy and mitophagy—the processes cells use to recycle damaged proteins and mitochondria. In mouse glaucoma models, Torin 2 reduced the buildup of abnormal mitochondria and preserved retinal ganglion cells, optic nerve axons, and electrical retinal responses. It also increased survival of retinal ganglion cells in human retinal tissue maintained in the laboratory. () The findings are important, but they do not establish Torin 2 as a treatment. The compound was given by injection into the mouse eye at a research concentration, it has broad kinase effects, visual behavior was not tested, and the study did not directly measure mitochondrial respiration or energy production. The most useful interpretation is narrower: > Glaucoma may involve a failure of mitochondrial quality control, and selectively restoring mitochondrial clearance could become a form of pressure-independent neuroprotection. What the Recent Torin 2 Study Actually Showed The experimental design The study used several complementary approaches: A glucocorticoid-induced ocular hypertension mouse model, in which eye pressure was elevated for 10 weeks. A mutant myocilin mouse model, representing a form of inherited open-angle glaucoma. Mt-Keima reporter mice, which allow researchers to measure mitophagy flux—the delivery of mitochondria to acidic lysosomes for degradation. Retinal ganglion-cell-specific deletion of autophagy-related gene 5, testing what happens when autophagy is removed directly from retinal ganglion cells. Human retinal explants, cultured outside the body under conditions that normally cause progressive retinal ganglion-cell death. () The investigators found that chronic eye-pressure elevation caused abnormal mitochondrial accumulation, oxidative DNA damage, and reduced mitophagy flux. Importantly, the mitophagy defect appeared before substantial retinal ganglion-cell loss, suggesting that impaired clearance may be an early event rather than merely a consequence of dying neurons. () Reported effects of Torin 2 For the full table, please open this article on visualfieldtest.com. The pattern electroretinogram result can be expressed in two ways: Compared with injured vehicle-treated eyes, the mean response was approximately 83% higher: \[ (31.82 - 17.36) / 17.36 \approx 83\% \] Relative to the entire deficit between injured eyes and non-hypertensive controls, Torin 2 closed approximately 92% of the electrophysiological gap: \[ (31.82 - 17.36) / (33.04 - 17.36) \approx 92\% \] These calculations should not be interpreted as “92% vision restoration.” Pattern electroretinogram amplitude is a laboratory measure of inner-retinal function, not the same as visual acuity or visual-field preservation. What happened when autophagy was removed? The genetic experiments strengthened the argument that autophagy is not merely an incidental response. When autophagy-related gene 5 was selectively removed from retinal ganglion cells: Pattern electroretinogram amplitude fell from 21.78 to 8.61 microvolts, a reduction of approximately 60%. Retinal ganglion-cell number fell by approximately 39%. The number of healthy optic nerve axons fell by approximately 59%. Swollen and abnormal mitochondria accumulated in retinal ganglion-cell axons. Oxidative DNA damage increased. () A separate 2026 study using autophagy-related gene 7 and autophagy-related gene 5 deletion found progressive retinal ganglion-cell and optic nerve degeneration without inducing high eye pressure. The retinal ganglion-cell bodies accumulated swollen mitochondria, distended endoplasmic reticulum, abnormal synaptic vesicles, and enlarged Golgi structures. () This supports the idea that normal, ongoing autophagy is necessary for retinal ganglion-cell housekeeping, even in the absence of glaucoma-related pressure elevation. What did Torin 2 do to “mitochondrial function”? The answer requires precision. Torin 2: increased measured mitophagy flux; reduced the accumulation of structurally abnormal mitochondria; improved the apparent pool of healthy mitochondria; reduced oxidative DNA damage; improved axonal transport and electrical retinal function. However, the study did not report direct measurements of: adenosine triphosphate production; oxygen consumption; respiratory-chain complex activity; mitochondrial membrane potential; calcium handling; mitochondrial adenosine triphosphate reserve. Therefore, it is safest to say that Torin 2 improved mitochondrial quality control and mitochondrial structural health, while direct restoration of mitochondrial bioenergetics remains to be demonstrated. Important limitations The study has several important limitations: Torin 2 was administered by intravitreal injection, not as a clinically practical eye drop or tablet. The reported concentration—1 millimolar in mice—cannot be translated directly into a human dose. The human experiment involved retinal tissue outside the body, exposed to 100 micromolar Torin 2 under artificial stress conditions. The treatment was tested over a relatively short period. The mutant myocilin model had a fall in eye pressure after Torin 2, making it difficult to separate direct neuroprotection from pressure reduction. The glucocorticoid model did not show an eye-pressure reduction, making that model more persuasive for pressure-independent retinal protection. No living-human safety data exist for Torin 2 as an eye treatment. No behavioral test of vision was performed. () Why Retinal Ganglion Cells Are So Dependent on Mitochondria Retinal ganglion cells are unusually vulnerable to energy failure for several anatomical and physiological reasons. They have long, energy-demanding axons Retinal ganglion-cell axons travel from the retina through the optic nerve and eventually to visual centers in the brain. Much of the axon within the retina and optic nerve head is unmyelinated. Unlike a myelinated nerve, an unmyelinated axon must continuously restore ion gradients along a large length of membrane after each electrical impulse. That requires constant activity from sodium-potassium pumps and other energy-consuming transport systems. Retinal ganglion cells also maintain large dendritic trees, synapses, and active transport pathways. Their energy demand is therefore high even at rest. () Mitochondria must be positioned throughout the neuron Mitochondria are not useful only in the cell body. They must be moved to: dendritic synapses; the axon initial segment; the optic nerve head; regions of high calcium influx; distant axonal terminals in the brain. The optic nerve head is particularly vulnerable because retinal ganglion-cell axons bend sharply and undergo major structural changes as they pass from the retina into the optic nerve. Their high mitochondrial density in this region reflects the need to support electrical activity and axonal transport. () Retinal ganglion cells cannot dilute damaged organelles by dividing Retinal ganglion cells are long-lived, postmitotic neurons. A dividing cell can distribute damaged proteins and organelles between daughter cells. A retinal ganglion cell cannot. It must repair, recycle, or remove its own damaged components for decades. This makes defective autophagy particularly dangerous. If damaged mitochondria are not removed, they can: produce excessive reactive oxygen species; release oxidized mitochondrial DNA; impair adenosine triphosphate production; disrupt calcium balance; activate apoptotic pathways; obstruct axonal transport; damage synapses and dendrites. The 2026 autophagy-deficiency study directly observed this type of intracellular accumulation in retinal ganglion cells. () Why Damage Can Continue Even When Eye Pressure Is Controlled Eye pressure remains important, but it is not the only determinant of retinal ganglion-cell survival. Pressure-related stress can initiate a chain of secondary problems: Compression or distortion at the optic nerve head. Impaired axonal transport. Reduced delivery of target-derived survival factors. Mitochondrial transport failure. Energy shortage and oxidative stress. Synapse and dendrite loss. Neuroinflammation and glial dysfunction. Irreversible retinal ganglion-cell death. Once this process becomes self-sustaining, lowering pressure may remove the original trigger without immediSupport the show